Medicine and Dentistry
Platelet
78%
Platelet Lysate
68%
Thrombocyte Concentrate
34%
Growth Factor
24%
Medicine
22%
Malignant Neoplasm
22%
Fibrin Glue
22%
Cell Therapy
20%
Blood Transfusion
20%
In Vitro
17%
Ex Vivo
14%
Blood Product
13%
COVID-19
13%
Biocompatible Material
13%
Pathogen
13%
Infection
13%
Disease
12%
Platelet Derived Growth Factor
12%
Serum Total Protein
12%
Fibrinogen
12%
Fetal Bovine Serum
11%
Circulating Tumor Cell
11%
Copurification
11%
Human Immunodeficiency Virus
10%
Low and Middle Income Countries
10%
Mesenchymal Stem Cell
9%
Blood Proteins
9%
Blood Clotting Factor
9%
Von Willebrand Factor
9%
Neuroprotective Agent
9%
Neoplasm
9%
Apheresis
8%
Surgical Anastomosis
8%
Endothelial Cell
8%
Tumor Progression
8%
Proteinase Inhibitor
8%
Immunoglobulin
8%
Blood Plasma
8%
Biological Therapy
7%
Nanofiltration
7%
Wound Healing
7%
Vasculotropin
7%
Bleeding
7%
Hepatitis B Virus
7%
Drug Sensitivity
7%
Cytokine
7%
Traumatic Brain Injury
7%
Hepatitis C Virus
6%
Biological Product
6%
Parkinson's Disease
6%
Pharmacology, Toxicology and Pharmaceutical Science
Plasma Protein
28%
Disease
27%
Blood Clotting Factor
26%
Blood Clotting Factor 8
24%
Fibrinogen
24%
Infectious Agent
23%
Growth Factor
23%
Von Willebrand Factor
23%
Malignant Neoplasm
22%
Immunoglobulin G
20%
HIV
20%
Thrombocyte Concentrate
19%
Infection
18%
Proteinase Inhibitor
17%
Neoplasm
17%
Immunoglobulin
14%
Hepatitis C Virus
13%
Tyloxapol
13%
Antivenom
12%
Tributyl Phosphate
11%
Biological Product
10%
Clinical Trial
9%
Sepharose
9%
Injury
9%
Biomaterial
9%
Thrombin
8%
Blood Clotting Factor 9 Concentrate
8%
Polyacrylamide Gel Electrophoresis
8%
Prion
8%
Bleeding
7%
Cytokine
7%
Nanoparticle
7%
Hepatitis B Virus
7%
Absence
7%
Microparticle
7%
Buffer
7%
Good Manufacturing Practice
7%
Thrombogenicity
7%
Fibrin Glue
7%
Hepatitis B
6%
Prothrombin Complex
6%
Enzyme-Linked Immunosorbent Assay
6%
Fresh Frozen Plasma
6%
Thrombosis
6%
Octanoic Acid
6%
SARS Coronavirus
6%
Therapeutic Use
6%
Reverse Phase High Performance Liquid Chromatography
6%
Complement Component C1s Inhibitor
6%
Alpha 1 Antitrypsin
6%
Immunology and Microbiology
Blood Plasma
100%
Platelet
63%
Cell Lysate
34%
Fractionation
29%
Infectious Agent
16%
Cryoprecipitate
13%
Intravenous Immunoglobulin
11%
Blood Transfusion
10%
Nanofiltration
10%
Growth Factor
10%
Human Immunodeficiency Virus
9%
Blood Product
9%
Fibrinogen
9%
Reverse Phase High Performance Liquid Chromatography
8%
Mesenchymal Stem Cell
7%
Hemocyte
7%
Surface Property
7%
Immunoglobulin G
7%
Molecular Weight
7%
Factor VIII
6%
Immunosuppressive Drug
6%
COVID-19
6%
Monospecific Antibody
6%
Cell Culture
5%
Hepatitis C Virus
5%
Microbiome
5%
